Elhan Webb | executive |
Richard Paulson | executive |
Reshma Rangwala | executive |
Sohanya Cheng | executive |
Michael Mason | executive |
Shea Feeney | analyst |
Maurice Raycroft | analyst |
Colleen Hanley | analyst |
Detlef Winckelmann | analyst |
Good morning. My name is Drew, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Third Quarter 2023 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.